Publisher
source

Mark Ward

Top university

3 months ago

Fully Funded PhD in Immunotherapy-Associated Thrombosis in Cancer Trinity College Dublin in Ireland

Degree Level

PhD

Field of study

Pharmacology

Funding

Four-year fully funded PhD supported by a Trinity Research Doctorate Award (TRDA). Includes a stipend of €25,000 per annum and fees covered. Expected start date: September 2026.

Deadline

Expired

Country flag

Country

Ireland

University

Trinity College Dublin

Social connections

How do I apply for this?

Sign in for free to reveal details, requirements, and source links.

Suggested positions

Keywords

Pharmacology
Biomarker Research
Biology
Vascular Biology
Single-cell Analysis
Medical Science
Tumor Immunology
Bioinformatic

About this position

Trinity College Dublin is advertising a fully funded 4-year PhD position in immunotherapy-associated thrombosis in cancer, based in the Department of Pharmacology and Therapeutics, School of Medicine. The project is supported by a Trinity Research Doctorate Award (TRDA) and will be carried out across Trinity College Dublin, the Trinity St James’s Cancer Institute, and St James’s Hospital.

This interdisciplinary PhD focuses on how cancer immunotherapy changes immune cells and blood vessels in ways that increase the risk of blood clots. The research combines immune and endothelial cell biology, single-cell transcriptomics, translational oncology, vascular biology, bioinformatics, and longitudinal patient cohorts to investigate the mechanisms driving immunotherapy-associated thrombosis and to support future biomarker development.

The successful candidate will receive training in experimental and computational methods, including primary cell culture, flow cytometry, thrombosis/coagulation assays, molecular biology, scRNA-seq analysis, translational bioinformatics, and scientific communication. The environment is described as supportive and multidisciplinary, with opportunities to work on cancer immunology, cancer metastasis, liquid biopsy research, and collaborative translational projects.

Funding: TRDA-funded PhD, fully funded for four years, with a stipend of €25,000 per annum and fees included. Expected start date is September 2026.

Eligibility: Open to graduates in immunology, biochemistry, pharmacology, molecular or cellular biology, biomedical science, or translational medicine. A minimum 2.1 honours degree or equivalent is required; a relevant master’s degree and prior lab/computational experience are desirable. Applicants must meet Trinity College Dublin PhD entry requirements.

Application: Send a CV, two referees’ contact details, and a one-page personal statement to Dr Mark Ward using the subject line PhD Application: Immunotherapy-Associated Thrombosis. Closing date: 19 June 2026.

Funding details

Four-year fully funded PhD supported by a Trinity Research Doctorate Award (TRDA). Includes a stipend of €25,000 per annum and fees covered. Expected start date: September 2026.

What's required

Applicants should have at least a 2.1 honours degree or equivalent in a relevant discipline such as immunology, biochemistry, pharmacology, molecular or cellular biology, biomedical science, or translational medicine. A master's degree in a relevant discipline is desirable. Prior laboratory or computational/bioinformatic research experience is desirable, including flow cytometry, cell culture, transcriptomic analysis, or R/Python. Applicants must meet Trinity College Dublin PhD entry requirements. Strong analytical and critical thinking, excellent written and verbal communication, ability to work independently and in a multidisciplinary team, organisation, attention to detail, and commitment to high-quality translational research are expected.

Ask ApplyKite AI

Start chatting
Can you summarize this position?
What qualifications are required for this position?
How should I prepare my application?

Professors